# Oruka Therapeutics, Inc.: Form 8-K, filed Dec 11, 2025

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: 8-K
- Filed: 2025-12-11
- Accepted by EDGAR: Dec 11, 2025, 16:10 ET
- Period: 2025-12-11
- Accession: 0001213900-25-120676
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000121390025120676/ea0268925-8k_oruka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000121390025120676/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000121390025120676/ea0268925-8k_oruka.htm

Filed Dec 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-120676. Last ingested by Listed: Nov 15, 2026, 02:43 ET. No prices; not investment advice.
